CLINICAL_TRIALS
trial_result
· 2019-11-01
Clinical Trial Update: Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"
Summary
Clinical trial update for leuprorelin injection kit in premenopausal breast cancer; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Premenopausal Breast Cancer | Status: COMPLETED | Results posted: 2019-11-01